BAP1 p.Ser63fs
c.188_189del · VCV3260370
Pathogenic
Single submitter
Classification
Pathogenic
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
Consequence
frameshift
predicted LoF
gnomAD v4.1
Rare
Conditions
1
hereditary neoplastic syndrome
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Consequence | frameshift | predicted loss-of-function in a haploinsufficient gene (ClinGen); NMD-escape possible for C-terminal truncations |
|---|---|---|
| Splicing | ||
| SpliceAI | — | not assessed · substitutions only |
| Constraint at this position | ||
| Conservation | phyloP 6.2 | GERP 1.8, phastCons 1 |
Predicted loss-of-function is descriptive, not an applied PVS1 code.
Variant & gene context
- Gene
- BAP1
- Protein
- p.Ser63fs
- Coding
- c.188_189del
- MANE Select
- NM_007212 · reported on NM_004656
- Type
- Microsatellite
- Location
- chr3:52408540 (GRCh38)
- Structure
- AlphaFold pLDDT 78.27 · 28 PDB
- Residue 63
- the 'interaction with hip2' region; a β-strand
Similar variants
- BAP1 p.Ser63Cys Uncertain significance ★★ ⚠ same residue
- BAP1 p.Ser63Phe Uncertain significance ★★ ⚠ same residue
- BAP1 p.Ser63= Likely benign ★★ same residue
- BAP1 p.Ser63Pro Uncertain significance ★ ⚠ same residue
- BAP1 p.Gln267fs Pathogenic ★★ same condition
- BAP1 p.Glu611fs Pathogenic ★★ same condition
- BAP1 p.His481fs Pathogenic ★★ same condition
- BAP1 p.Ser492fs Pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/bap1-p-ser63fs (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown